Submission Details
| 510(k) Number | K950134 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 13, 1995 |
| Decision Date | March 21, 1995 |
| Days to Decision | 67 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K950134 is an FDA 510(k) clearance for the URINE COCAINE METABOLITE SCREEN FLEX(TM) REAGENT CATRIDGE, a Hemagglutination, Cocaine Metabolites (benzoylecgnonine) (Class II — Special Controls, product code DLN), submitted by E.I. Dupont DE Nemours & Co., Inc. (Wilmington, US). The FDA issued a Cleared decision on March 21, 1995, 67 days after receiving the submission on January 13, 1995. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3250.
| 510(k) Number | K950134 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 13, 1995 |
| Decision Date | March 21, 1995 |
| Days to Decision | 67 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DLN — Hemagglutination, Cocaine Metabolites (benzoylecgnonine) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3250 |